Meeting News

Cost-effective drug found to prevent hepatitis C transmission in kidney transplantation

May 30, 2020
A short course of direct-acting anti-viral prophylaxis may be effective in preventing transmission of hepatitis C virus from kidney donors to…


VIDEO: Treating liver diseases during COVID-19

May 22, 2020
In this exclusive video, Nancy S. Reau, MD, section chief of hepatology and associate director of organ transplantation at Rush University Medical…

In the Journals

Universal screening reveals ‘striking’ HCV antibody prevalence in people born after 1965

May 15, 2020
Universal hepatitis C virus screening in EDs with the ability to opt out showed that nearly half of infections were identified in people born after…

Meeting News

HCV treatment through telehealth highly effective regardless of DAA regimen

May 11, 2020
Using the American Association for the Study of Liver Diseases and Infectious Diseases Society of America guidelines, treatment for HCV in the…

FDA News

FDA approves Epclusa for pediatric HCV

March 20, 2020
Epclusa is now available for the treatment of children with any of the six genotypes of hepatitis C virus after obtaining approval from the FDA…

Meeting News

Kidneys with hepatitis C virus increasingly transplanted in last 4 years

March 17, 2020
PHOENIX — Since 2016, kidneys from donors with hepatitis C virus are being discarded less and transplanted more, according to a speaker at…

In the Journals

Aspirin may reduce risk for hepatocellular carcinoma, liver-related mortality in chronic viral hepatitis

March 11, 2020
Low-dose aspirin use appeared associated with significantly lower risk for hepatocellular carcinoma and lower liver-related mortality among patients…

In the Journals

Study confirms relevance of SVR endpoint for patients receiving HCV treatment

February 28, 2020
SVR, which has been challenged in regard to its association with clinical outcomes, has been confirmed as a prognosis-altering endpoint in patients…

In the Journals

Kidneys from donors with hepatitis C virus increased recipient life expectancy, reduced costs

February 27, 2020
Transplanting kidneys from donors with hepatitis C virus into uninfected recipients reduced costs to the health care system, while also increasing…

In the Journals

DDIs affect around 40% of HCV patients taking DAAs

February 24, 2020
Drug-drug interactions, or DDIs, affect about 40% of patients with hepatitis C virus being treated with direct-acting antivirals, or DAAs, according…

In the Journals

90% of injection drug users miss opportunities for HIV or HCV testing

February 20, 2020
Using data from more than 840,000 health care encounters, researchers estimated that around 90% of people who inject drugs missed opportunities for…

In the Journals

Estimated global prevalence of pediatric HCV at more than 3 million

January 29, 2020
An analysis of peer-reviewed articles provided global prevalence estimates of hepatitis C virus in children, according to data from a modelling…

In the Journals

Patient support tool may improve treatment decisions for those with CKD, hepatitis C

January 20, 2020
For patients with both chronic kidney disease and the hepatitis C virus, an education and support tool increased knowledge of the conditions, thereby…

In the Journals

‘Pathway code’ for HCV test orders improves screening, linkage to care

January 13, 2020
Implementation of a multifaceted hepatitis C care pathway improved screening and linkage to care rates, especially among baby boomers, or those born…

8 reports on safety of HCV positive-to-negative organ transplants

January 10, 2020
The “direct-acting antiviral era” for hepatitis C has been a novel step forward in medicine with several regimens providing cure rates of…

In the JournalsPerspective

HCV-positive donor hearts confer similar outcomes to HCV-negative hearts

January 8, 2020
Patients who received a hepatitis C virus-positive donor heart experienced similar posttransplant survival, drug-treated rejection, postoperative…

In the Journals

Sexually transmitted HCV rates high among MSM regardless of HIV status

January 7, 2020
Researchers found high rates of sexually transmitted hepatitis C among HIV-negative men who have sex with men who used pre-exposure prophylaxis…

In the JournalsPerspective

Infections caused 13% of cancers in 2018

January 6, 2020
In 2018, infections were the cause of 13% of all new cancer diagnoses, totaling 2.2 million new cases worldwide, although these totals do not include…

In the Journals

HCV elimination program helps identify infection, begin treatment

December 23, 2019
Georgia’s hepatitis C virus elimination program made significant progress in helping diagnose patients and begin treatment, according to a…

In the Journals

Treatability of HCV from heart transplants may broaden donor pool

December 18, 2019
The donor pool for heart transplants can potentially be expanded now that the infection from donor-derived hepatitis C is curable and well tolerated…